Snowball logo
logo
1541

ImmuneOnco Biopharms

1541 β€’ HK
HK$3.21+HK$0.005Β  (0.16%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
13.815.0240670.35099469.68150.3269.6
COGS
--(0.0351)-15.31-
Gross Profit
13.815.0240676.99714869.68135261.4
Operating Expenses & Income
Operating Income
(210.5)(321.8)(331.6)(289.5)(217.3)(505.5)
Total Operating Expenses
224.3326.8338.6359.1352.3754.2
R&D Expenses
176244.9265.5303.3313.9657.9
Selling General & Admin Expenses
48.3281.9473.1360.9153.94109.8
Earnings from Continuing Operations
Interest Expense
(0.891)(0.694893)(1.38579)(3.240899)(5.166725)(18.11)
Interest Income
1.640.6948931.385793.2408995.3047.204939
Income Tax Expense
12.94---0.02820.0515
Net Income
Net Income
(732.9)(355.7)(345)(296.8)(212.9)(522.7)
Supplemental
EBIT
(732.1)(355)(343.7)(289.5)(217.3)(506.6)
EBITDA
(718.9)(339.5)(323.1)(277.8)(203)(485.6)
In millions of HKD, except % and values per 1 share